Advocacy Actions

2019-10-10 > Beijing

European Chamber Healthcare Equipment Working Group Rep. Presents “Buy China” policy issue at the EU Delegation to China

European Chamber Healthcare Equipment Working Group Rep. Presents “Buy China” policy issue at the EU Delegation to China

Read more
2019-10-09 > Beijing

Meeting with the Centre for Medical Device Evaluation on the Technical Guideline of Methodological Comparison Techniques for In Vitro Diagnostic Reagent Exempted from Clinical Trials

On 9th October, the Centre for Medical Device Evaluation held a meeting on the Technical Guideline of Methodological Comparison Techniques for In Vitro Diagnostic Reagent Exempted from Clinical Trials.

Read more
2019-09-30 > Beijing

Comments to the Centre for Medical Device Evaluation on Further Specification of the Clinical Evaluation Section of eRPS

On 30th September, the medical devices sector submitted comments to the Centre for Medical Device Evaluation on further specification of the Clinical Evaluation Section of eRPS.

Read more
2019-09-27 > All chapters

President Jörg Wuttke Meets with H.E. Ambassador Zhang Ming, Head of Chinese Mission to the European Union

On 27th September, in Brussels, European Chamber President Jörg Wuttke visited Ambassador of Mission of the People’s Republic of China to the European Union, His Excellency (H.E.) Zhang Ming. President Wuttke was warmly received by Ambassador Zhang and his team at his residence.

Read more
2019-09-27 > Beijing

Meeting with Technical Regulatory Affairs of Cosmetics Europe on cosmetics regulation

On 27 September, Cosmetics working group met with Gerald Renner, Director of Technical Regulatory Affairs of Cosmetics Europe, to exchange cosmetics regulation updates from both the European Union and China.

Read more
2019-09-25 > Beijing, Nanjing

Advocacy Letter to the Healthcare Security Administration of Jiangsu Province on 'Volume-Based Procurement'

The Healthcare Equipment (HCE) Working Group sent an advocacy letter to the Healthcare Security Administration (HSA) of Jiangsu Province, asking to postpone the second round of 'volume-based procurement' of high-value consumable medical devices.

Read more
2019-09-25 > Beijing

Meeting with Deputy Director General Zhang Chun of Fiscal, Financial Affairs and Credit Building Department, NDRC, on China’s Corporate Credit System

On 25th September, led by Secretary General Adam Dunnett, a European Chamber delegation paid a visit to the Fiscal, Financial Affairs and Credit Building (FFACB) Department, National Development and Reform Commission (NDRC), to meet with the deputy director general (DDG), Zhang Chun, on corporate social credit system issues. The director of the Foreign Investment Administration Department of the Ministry of Commerce, deputy directors of the National Public Credit Information Centre and representatives of the FFACB Department also attended the meeting.

Read more
2019-09-25 > Beijing, Southwest China

Meeting with Chairman of China Council for the Promotion of International Trade (CCPIT) Chengdu Sub-council

On 25th morning, Vice President Massimo Bagnasco and Beijing Chapter General Manager Carl Hayward received the representatives from Chengdu Municipal Government and met with Mr Chen Fu, chairman director of CCPIT Chengdu Sub-council.

Read more
2019-09-25 > Beijing

Comments to the NMPA's Notice on Matters Related to the First Batch of Implementation of the Unique Device Identification of Medical Devices (Call for Comment)

On 25th September, the medical devices sector submitted comments to the National Medical Products Administration on the Notice on Matters Related to the First Batch of Implementation of the Unique Device Identification of Medical Devices (Call for Comment).

Read more
2019-09-25 > Beijing

Comments to National Medical Products Administration (NMPA) on Catalog of Remaining Licensing Items in Medical Products Supervision System (Draft for Comments)

On 25 September, Comments on Catalog of Remaining Licensing Items in Medical Products Supervision System (Draft for Comments) were sent to National Medical Products Administration (NMPA).

Read more